What is PERMIT ?

Launched in January 2020, the H2020-funded PERMIT will develop recommendations for robust and reproducible personalised medicine research.

Bringing All Stakeholders to the Table

PERMIT brings together field experts, funding bodies, patient representative associations, medicine agencies, HTA authorities, and other key stakeholders from across Europe to collaborate in every stage of the project. The goal is to reach consensus and broad acceptability of the proposed methodological recommendations.

Meet the members

5 Main Work Packages

PERMIT aims to enhance personalised medicine research through various activities.

WP2

Literature mapping on methods in personalised medicine and gap analysis (foundation for WP3-6)

Read more

WP3

Recommendations on stratification cohort design, data collection, quality / traceability, management 

Read more

WP4

Recommendations on the use of machine learning for stratification algorithms

Read more

WP5

Recommendations on translational research for treatment selection

Read more

WP6

Recommendations on the design of randomised trials in personalised medicine

Read more

PERMIT in Numbers

2020

Project Launch

24

Project Months

12

Consortium Members

7

Work Packages